
ACRV P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.54
Average-0.5365
Median-0.5300
Minimum-0.6100
Maximum-0.4700
-0.54
Past Month-0.04 (8.00%)
The P/E ratio for ACRV is -0.54 as of Jun 13, 2025. This represents a decrease of -73.00% compared to its 12-month average P/E ratio of -2. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Acrivon Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Acrivon Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Acrivon Therapeutics Inc to industry peers.
Acrivon Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Acrivon Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Acrivon Therapeutics Inc to industry peers.
ACRV P/E Ratio Insights
See Acrivon Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ACRV
Order type
Buy in
Order amount
Est. shares
0 shares
ACRV P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $1.11 | -0.50 |
May 1, 2025 | $1.33 | -0.55 |
Apr 1, 2025 | $1.68 | -0.69 |
Mar 3, 2025 | $5.14 | -1.90 |
Feb 3, 2025 | $5.57 | -2.06 |
Jan 2, 2025 | $5.69 | -2.11 |
ACRV End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.54 | -75.78% |
2024 | -2.23 | +4.21% |
2023 | -2.14 | — |
FAQs About Acrivon Therapeutics Inc (ACRV) P/E ratio
The latest P/E ratio of ACRV is -0.54, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Acrivon Therapeutics Inc’s last 12-month average P/E ratio is -2, compared to its current P/E ratio of -0.54. This reflects a decrease of -73.00%.
Acrivon Therapeutics Inc’s current P/E ratio of -0.54 is lower than its last 12-month average P/E of -2. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Acrivon Therapeutics Inc’s average P/E ratio over the last 3 years is -3.25. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Acrivon Therapeutics Inc’s average P/E ratio over the last 5 years is -1.95. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.